Recent Antiphospholipid Syndrome News:
- Antiphospholipid syndrome and recurrent pregnancy losses – ScienceDirect.com
- Bilateral Adrenal Hemorrhage in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
- Antiphospholipid Syndrome Market Size is anticipated to grow – openPR.com
- increase of monocyte/high-density lipoprotein cholesterol ratio precedes recurrent …
- How can nursing homes protect more patients from infections? – Michigan Medicine
- Eliquis doesn’t cause as much bruising as Coumadin – PressReader
- Cardiovascular risk factors and target attainment a concern in APS | springermedicine.com
- America doesn’t have enough hospital beds. This could help | University of Michigan Health
- Renal, Hepatic and other Intraabdominal Manifestations in the Antiphospholipid Syndrome
- Too Little CV Risk Factor Control Seen in Patients With APS – Medscape
- Truvian Receives FDA 510(k) Clearance for Multimodal Benchtop Analyzer | 360Dx
- Prior mental health diagnosis may predict neuropsychiatric outcomes in childhood lupus
- VNRX: 3Q 2025 results reported; Revenues & EPS above our expectations; cost cutting very …
- Hypertrophic Cardiomyopathy (HCM) | University of Michigan Health
- Terrible APS (TrAPS) – A newly defined variant of severe APS – Frontiers
- Catastrophic antiphospholipid syndrome following surgery for Libman–Sacks endocarditis
- Ianalumab shows ‘meaningful, disease-modifying results’ vs placebo in Sjögren’s – Healio
- Clinical presentation of antiphospholipid syndrome – ScienceDirect.com
- BREAKING STUDY: COVID-19 “Vaccines” Linked to Multiple Sclerosis, Lupus, Type 1 …
- Blood Test Reveals Risks in Antiphospholipid Syndrome, SLE – Medscape
- Reproductive health outcomes in rheumatic diseases highlighted at ACR Convergence 2025 – Healio
- Thrombophilia Industry Report: Competitive Landscape and Future Prospects
- Massive Pulmonary Embolism in the Postpartum Period as the First Manifestation of …
- Inhibition of FKBP5 alleviates obstetric antiphospholipid syndrome by regulating … – Nature
- Europe and USA High Performance Epoxy Coating Market Outlook 2025–2035
- Europe and U.S. Catastrophic Antiphospholipid Syndrome Market Outlook 2025–2035
- Catastrophic Antiphospholipid Syndrome Market | Global Market Analysis Report – 2035
- Avascular necrosis in antiphospholipid syndrome: pathophysiology, risk factors, and management
- EULAR develops new disease activity score for antiphospholipid syndrome
- Maternal and Neonatal Outcomes in Obstetric Antiphospholipid Syndrome – Frontiers
- A Challenging Case of Recalcitrant Facial and Disseminated Rash in a Patient with …
- UPSC Prelims Current Affairs for 19 November 2025 – Vajiram & Ravi
- SIMS Hospital Saves 29-Year-Old From Rare Multi-organ Clot And Recurrent Stroke
- Balancing Bleeding and Thrombosis: A Rare Case of Hereditary Hemorrhagic … – Cureus
- Tetrachloroethylene, Health Impacts, Applications, Latest News – Vajiram & Ravi
- Raulane Festival, State, Importance, Latest News – Vajiram & Ravi
- Antiphospholipid Syndrome (APS), Causes, Symptoms, Treatment, Latest News
- Surging Autoimmune Disorder Prevalence Fuels Antiphospholipid Syndrome Treatment Market
- Study: Autoimmune impacts of CAR T-cell therapy require monitoring – Healio
- Gynecologic Care – Routine | University of Michigan Health
- Comment on: Vascular liver disorders in patients with antiphospholipid syndrome: a national …
- VolitionRx reports Q3 revenue $600,000, consensus $715,590 – TipRanks.com
- VolitionRx Limited Announces Third Quarter 2025 Financial Results and Business Update
- Autoimmune Adrenalitis in Systemic Lupus Erythematosus: Identifying a Rare Endocrine …
- Thermo Fisher Scientific Obtains 510(k) Clearance for Exent Immunoglobulin Isotypes Analyzer
- Pathophysiology of Primary Budd-Chiari Syndrome: A Narrative Review | Cureus
- SLE in Veterans Increases Maternal Pregnancy Risks – Ophthalmology Advisor
- Catastrophic Antiphospholipid Syndrome Market in 2025 Detailed Study Analysis
- A man is rapidly being brain-damaged because doctors refuse to believe he’s sick – Canary
- The D. Dan and Betty Kahn Health Care Pavilion Floor Maps – Michigan Medicine
Antiphospholipid Syndrome News:
- Nine research updates in thrombosis treatment, surveillance and risk prediction.
-
Antiphospholipid syndrome. This review summarizes the main knowledge on the clinical and therapeutic aspects of this syndrome.
-
Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Thrombotic complications are the most common cause of death in APS.
-
Heart attack: New finding may change the face of treatment
-
Hughes syndrome (antiphospholipid syndrome) and the nervous system.
-
When autoimmune diseases exert neuro-ophthalmic effects
-
Catastrophic antiphospholipid syndrome: The current management approach.
- 2016 review on catastrophic antiphospholipid syndrome.
-
Pregnancy and APS: Results Look Encouraging
-
The Role of Viral Infections and Vaccines in the Pathogenesis of Antiphospholipid Syndrome
-
Anticoagulating patients with high-risk acquired thrombophilias.
-
Infectious, Noninfectious Postoperative Complications More Frequent in Patients With SLE
-
Catastrophic antiphospholipid syndrome: The current management approach.
- Rapidly progressive coronary artery disease as the first manifestation of antiphospholipid syndrome. case report
- C-sections raise blood clot risk; protection urged in new recommendation from American College of Obstetricians and Gynecologists. CBS News,
- Myasthenia gravis is sometimes found in conjunction with antiphospholipid syndrome with: A case report
- Primary antiphospholipid syndrome should be considered as a possible cause of repeated stent thrombosis. Journal of Cardiology Cases.
- Good news for prospective mothers with antiphospholipid syndrome? – Journal of Postgraduate Medicine
- New study suggests that long-term anticoagulation with low molecular weight heparin (LMWH) may be a safe and effective alternative for APS patients who had not responded to warfarin (Coumadin) – Annals of Rhematic Diseases
- Rheumatologist Dr. Doruk Erkan talks about Antiphospholipid Syndrome (APS), the disorder that caused my stroke, in this Q&A with the Hospital for Special Surgery. Read it to learn more about APS. – Dr. Doruk Erkan, Rheumatologist
- Preeclampsia: New Research Reveals Why Preeclampsia More Likely For Some Women – Mattason’s Review
